SEI Investments’s Avadel Pharmaceuticals AVDL Stock Holding History

SEI Investments’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-32,535	Closed	-$701K	–	3243
2025 Q4	$701K	Buy	+32,535	New	+$632K	﹤0.01%	2345
2018 Q1	–	Sell	-84	Closed	-$1K	–	3461
2017 Q4	$1K	Sell	84 -17,320	-100%	-$162K	﹤0.01%	3177
2017 Q3	$183K	Buy	17,404 +4,678	+37%	+$44.7K	﹤0.01%	1909
2017 Q2	$140K	Buy	12,726 +2,900	+30%	+$29.1K	﹤0.01%	1974
2017 Q1	$95K	Sell	9,826 -859	-8%	-$8.59K	﹤0.01%	1958
2016 Q4	$111K	Sell	10,685 -644	-6%	-$7.08K	﹤0.01%	1936
2016 Q3	$140K	Buy	11,329 +4,658	+70%	+$60.9K	﹤0.01%	1781
2016 Q2	$72K	Buy	6,671 +4,810	+258%	+$51.3K	﹤0.01%	1829
2016 Q1	$21K	Sell	1,861 -172,519	-99%	-$1.71M	﹤0.01%	2037
2015 Q4	$2.13M	Buy	+174,380	New	+$2.72M	0.01%	985

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

SEI Investments's AVDL Position: Q1 2026 in Review

SEI Investments sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 32,535 shares — an estimated $701K sold.

SEI Investments first reported a position in AVDL in Q4 2015 and held it in 10 quarters. The position peaked at $2.13M in Q4 2015. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

SEI Investments reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
SEI Investments sold 32,535 Avadel Pharmaceuticals shares in Q1 2026, an estimated $701K.
SEI Investments first reported a position in Avadel Pharmaceuticals in Q4 2015 and held it in 10 quarters.
SEI Investments's Avadel Pharmaceuticals position peaked at $2.13M in Q4 2015.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.